Venkata Doppalapudi

Venkata Doppalapudi started their work experience in 2000 as a Research Scientist at NewBiotics, where they worked until 2002. In 2002, they joined Ontogen as a Senior Scientist, where they evaluated high throughput screening hits and initiated a new antibacterial project. Venkata then moved to CovX in 2003, where they worked as a Senior Scientist-II, acting as a project leader and developing technology. In 2006, Venkata joined Pfizer/CovX as a Senior Principal Scientist/Group Leader, initiating new programs, and delivering preclinical candidates. Venkata continued working at Pfizer from 2009 to 2013 as an Associate Research Fellow, leading chemistry efforts in the oncology therapeutic area, establishing new programs, and managing research projects. Finally, Venkata joined Avidity Biosciences LLC in 2013 as the Director of Chemistry, later becoming a Senior Director and currently serving as the Vice President of Chemistry.

Venkata Doppalapudi pursued their education in the field of Organic Chemistry at the Indian Institute of Chemical Technology, India. From 1991 to 1996, they completed their Doctor of Philosophy (PhD) degree at the aforementioned institution.